The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.
Explore the 2026 Medicare payment updates for hospice, rehab, and psychiatric care, hospital efficiency initiatives amid rising costs, and growing use of agentic AI in healthcare settings.
Study reveals Medicare spends $4.4 billion annually on low-value tests and procedures in older adults, urging evidence-based reforms to reduce waste and enhance care quality.
Explore the latest developments in Medicare for 2025 including UnitedHealthcare's market exits, anticipated drug price increases, new rural hospital funding legislation, and changes to Medicare Savings Programs affecting coverage and costs.
The AMA report reveals high market concentration among pharmacy benefit managers (PBMs), vertical integration with insurers, and calls for increased transparency and regulatory reforms to control drug prices and enhance competition.
The AHCA is actively seeking Medicare Advantage data from providers to ensure compliance with prior authorization and regulatory guidelines, while studies reveal key unmet needs pushing seniors with dementia toward nursing homes.
Explore how initial enrollment in Medicare Advantage plans affects the ability to switch back to original Medicare and obtain Medigap coverage without penalties or underwriting issues.
In 2025, the SSA notified over 850,000 ZIP codes about Medicare programs like Extra Help and Medicare Savings Programs that aid with medical and prescription costs. Many eligible beneficiaries remain unaware of these savings opportunities.
Marking 60 years of Medicare and Medicaid, recent legislation threatens major cuts increasing costs and reducing coverage for millions, including New Hampshire residents.
In 2025, the SSA notified over 850,000 ZIP codes about Medicare Extra Help and Medicare Savings Programs, emphasizing eligibility criteria and benefits available to reduce beneficiaries' out-of-pocket costs on prescription drugs and medical expenses.
